The role of xenobiotics in triggering psoriasis
- 24 August 2020
- journal article
- review article
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (12) , 3959-3982
Abstract
Psoriasis is a common inflammatory skin disease affecting approximately 2% of the world population. A complex interplay of genetic predisposition and risk factors contributes to the risk of its onset. Several xenobiotics have been implicated in the pathogenesis of psoriasis. Drugs are among the most investigated trigger factors; strong association with disease induction or exacerbation has been reported for β-blockers, lithium, NSAIDs and ACE inhibitors, all of which are commonly used in the management of various comorbidities in psoriasis patients. Furthermore, inhibitors of TNF have a well-documented potential for triggering new-onset psoriasis when used for other indications (e.g. Crohn’s disease or rheumatoid arthritis), while post-marketing data have revealed the same association for ustekinumab. Several other drugs have been connected with psoriasis, but the evidence is less compelling. Smoking and alcohol have been reported to increase the risk for occurrence of psoriasis, but can also affect unfavorably the course of the disease and its response to treatment. Furthermore, exposure to secondhand smoke, especially in childhood, also mediates the risk. Emerging data now suggest that air pollution also has a detrimental effect on skin disease, including psoriasis, but this association needs further investigation. Understanding of the toxic effect of xenobiotics on the initiation and clinical course of psoriasis can contribute to its better control, as it can help with the avoidance of triggering factors and, in some cases, influence the success of pharmacological treatment. It, therefore, has an important place in the comprehensive management of psoriasis.Keywords
Funding Information
- The Slovenian Research and Innovation Agency
This publication has 209 references indexed in Scilit:
- Smoking and Risk of Incident Psoriasis Among Women and Men in the United States: A Combined AnalysisAmerican Journal of Epidemiology, 2012
- Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin DiseaseAnnals of Dermatology, 2012
- Alcohol Intake and Risk of Incident Psoriasis in US WomenArchives of Dermatology, 2010
- PsoriasisNew England Journal of Medicine, 2009
- Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cellsProceedings of the National Academy of Sciences, 2008
- Drug-induced psoriasis—A retrospective chart review performed at the University of Oklahoma Department of DermatologyJournal of the American Academy of Dermatology, 2008
- Beta Adrenergic Receptors in KeratinocytesDermatologic Clinics, 2007
- Alcohol abuse and treatment resistance in skin diseaseJournal of the American Academy of Dermatology, 1994
- Alcohol intake and treatment responsiveness of psoriasis: A prospective studyJournal of the American Academy of Dermatology, 1993
- Psoriasis and drugs: Influence of tetracyclines on the course of psoriasisJournal of the American Academy of Dermatology, 1988